Declaration of Helsinki, 2008: implications for stakeholders in research

Area of Science:

• Medical Ethics
• Clinical Research Governance

Background:

• The Declaration of Helsinki (DoH) was established by the World Medical Association (WMA) in 1964.
• It serves as a foundational ethical guideline for medical research involving human subjects.
• The DoH has been amended multiple times, with the latest version adopted in 2008.

Purpose of the Study:

• To discuss the significant aspects of the 2008 Declaration of Helsinki.
• To analyze the impact of the 2008 DoH on various stakeholders in the research ecosystem.
• To highlight key ethical considerations in contemporary human subject research.

Main Methods:

• Review of the 2008 Declaration of Helsinki (DoH) document.
• Analysis of ethical principles and guidelines outlined in the 2008 version.
• Discussion of the implications for different research participants and bodies.

Main Results:

• The 2008 DoH addresses critical issues: participant safety, inclusion of underrepresented groups, clinical trial registration, post-study access, data and tissue usage, compensation for research injuries, and placebo use.
• This version significantly influences the responsibilities and practices of investigators, ethics committee members, sponsors, authors, editors, and reviewers.
• The updated guidelines aim to enhance ethical conduct and protect human subjects in evolving research landscapes.

Conclusions:

• The 2008 Declaration of Helsinki provides a comprehensive ethical framework for medical research.
• Adherence to the 2008 DoH is crucial for ensuring participant welfare and research integrity.
• Understanding the 2008 DoH is essential for all individuals and institutions involved in human subject research.